Virtus LifeSci Biotech Clinical Trials ETF (BBC) Holdings $21.60 -0.28 (-1.28%) As of 07/18/2025 04:10 PM Eastern Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsRatingsShort InterestBuy This Stock Top 50 BBC HoldingsRankCompanyCurrent PriceWeightShares Held1Bny Mellon Cash Reserve UsdN/A3.86%409,1072VERVVerve Therapeutics$10.91-0.4%1.54%14,6663PRTAProthena$6.26-3.2%1.05%18,2824NUVBNuvation Bio$2.31+3.1%0.98%51,2115NTLAIntellia Therapeutics$12.06+1.9%0.97%11,1006CNTACentessa Pharmaceuticals$15.69-1.7%0.95%7,6997ABCLAbCellera Biologics$4.48+14.9%0.93%29,4268ARQTArcutis Biotherapeutics$14.67-5.2%0.93%6,8669TNGXTango Therapeutics$6.77-1.3%0.92%18,35510XERSXeris Biopharma$5.11-2.3%0.92%20,971 Get the Latest News and Ratings for BBC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virtus LifeSci Biotech Clinical Trials ETF and its competitors with MarketBeat's FREE daily newsletter. 11ETNB89BIO$10.49-1.5%0.91%9,63512ORICOric Pharmaceuticals$11.01-1.2%0.91%9,58513AUTLAutolus Therapeutics$2.41-0.4%0.90%43,11114ELVNEnliven Therapeutics$22.66-2.9%0.90%4,71515LENZLENZ Therapeutics$33.73-2.4%0.90%3,13416OLMAOlema Pharmaceuticals$4.41-2.2%0.90%22,83017SANASana Biotechnology$4.63+4.0%0.90%36,49318SLNSilence Therapeutics$6.04-2.9%0.90%16,59619ITOSiTeos Therapeutics$10.260.89%9,28820MLTXMoonLake Immunotherapeutics$53.09-2.0%0.89%2,10621PHVSPharvaris$23.25-2.0%0.89%5,38022SLNOSoleno Therapeutics$87.20-0.5%0.89%1,15623SMMTSummit Therapeutics$26.20-5.2%0.89%4,59824AKROAkero Therapeutics$52.08-4.1%0.88%1,73125ATXSAstria Therapeutics$5.97-4.3%0.88%16,55126CLDXCelldex Therapeutics$22.41-2.4%0.88%4,55527COGTCogent Biosciences$12.49+2.4%0.88%12,83828KROSKeros Therapeutics$13.75-4.2%0.88%6,79529NRIXNurix Therapeutics$11.21-7.3%0.88%7,75030ARCTArcturus Therapeutics$13.50-0.3%0.87%7,33331BLTEBelite Bio$60.92-0.1%0.87%1,49132SRRKScholar Rock$40.72-5.0%0.87%2,78233GPCRStructure Therapeutics$19.25-1.4%0.87%4,17234ALTAltimmune$4.08+0.7%0.86%12,96435APGEApogee Therapeutics$39.31+0.8%0.86%2,21436ARVNArvinas$7.35-5.3%0.86%12,24437CYTKCytokinetics$37.23-4.3%0.86%2,79238IRONDisc Medicine$57.770.0%0.86%1,75839KYMRKymera Therapeutics$46.18-0.4%0.86%1,96040MREOMereo BioPharma Group$1.77-0.6%0.86%33,341I was wrong about Trump (Ad)I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.Let me show you exactly what we’re doing to prepare.41RAPPRapport Therapeutics$14.68-1.1%0.86%8,32042STOKStoke Therapeutics$13.22+7.0%0.86%7,84243ANABAnaptysBio$25.92-2.8%0.85%3,96044CGONCG Oncology$26.75-6.0%0.85%3,49845IMVTImmunovant$17.91-2.0%0.85%5,81546NUVLNuvalent$83.40-2.7%0.85%1,19047RVMDRevolution Medicines$38.30-1.9%0.85%2,25548VIRVir Biotechnology$5.41-1.5%0.85%17,75749WVEWAVE Life Sciences$8.34+4.1%0.85%12,87350AVBPArriVent BioPharma$22.05-2.9%0.84%3,923 Geographic ExposureUnited States85.7%Netherlands2.5%Canada2.4%Ireland2.0%Cayman Islands1.0%Singapore0.9%Virgin Islands, British0.8%Currency ExposureUSD100.0%Sector ExposureHealth Care96.2%Energy0.7%Consumer Discretionary0.4%Industry ExposureBiotechnology83.6%Pharmaceuticals11.7%Diversified Consumer Services1.3%Renewable Energy0.7%SubIndustry ExposureBiotechnology80.0%Pharmaceuticals12.9%Renewable Energy Equipment0.7%Coupon Exposure0-21.1% Related Companies and Tools Related Companies FTXH Portfolio MEDX Portfolio MEDI Portfolio TMED Portfolio PILL Portfolio GDOC Portfolio JDOC Portfolio LGHT Portfolio HYLG Portfolio BBP Portfolio This page (NYSEARCA:BBC) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Clinical Trials ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Clinical Trials ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BBC Stock Alerts